Clinical Trial Update: Evaluation of HRQoL in Adult With Immune Thrombocytopenia in China

View source ↗

Summary

A clinical trial update evaluating health-related quality of life in adults with immune thrombocytopenia in China; no drugs or results are specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Snippet

Sponsor: Shandong University | Conditions: Immune Thrombocytopenia | Status: UNKNOWN